SPf66, a chemically synthesized subunit malaria vaccine, is safe and immunogenic in Tanzanians exposed to intense malaria transmission
- 31 December 1994
- Vol. 12 (4), 328-336
- https://doi.org/10.1016/0264-410x(94)90097-3
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- A trial of the synthetic malaria vaccine SPf66 in Tanzania: rationale and designVaccine, 1994
- SPf66: Research for development or development of research?Vaccine, 1994
- Absence of seasonal variation in malaria parasitaemia in an area of intense seasonal transmissionActa Tropica, 1993
- Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in ColombiaThe Lancet, 1993
- The first field trials of the chemically synthesized malaria vaccine SPf66: safety, immunogenicity and protectivityVaccine, 1992
- Study of the safety and immunogenicity of the synthetic malaria SPf66 vaccine in children aged 1–14 yearsVaccine, 1992
- Studies on the humoral immune response to a synthetic vaccine against Plasmodium falciparum malariaClinical and Experimental Immunology, 1991
- How much malaria is there worldwide?Parasitology Today, 1989
- A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malariaNature, 1988
- Human Malaria Parasites in Continuous CultureScience, 1976